Kortagere; Sandhya

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kortagere; Sandhya.The latest application filed is for "novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease".

Company Profile

9.15.21

Kortagere; Sandhya - Newtown PA
KORTAGERE; Sandhya - Newton PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel D3 Dopamine Receptor Agonists To Treat Dyskinesia In Parkinson's Disease App 20220233475 - Kortagere; Sandhya ; et al.	2022-07-28
Glutamate transporter activators and methods using same Grant 11,377,452 - Kortagere , et al. July 5, 2	2022-07-05
Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same Grant 11,345,696 - Kortagere , et al. May 31, 2	2022-05-31
D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease Grant 11,266,612 - Kortagere , et al. March 8, 2	2022-03-08
Method For Synthesizing D3 Dopamine Receptor Agonists App 20220009876 - SIELECKI-DZURDZ; Thais Motria ; et al.	2022-01-13
Methods of Treating or Preventing an Attention Disorder, Cognitive Disorder, and/or Dementia Associated with a Neurodegenerative Disorder App 20200397721 - KORTAGERE; Sandhya	2020-12-24
Novel D3 Dopamine Receptor Agonists To Treat Dyskinesia In Parkinson's Disease App 20200390728 - KORTAGERE; Sandhya ; et al.	2020-12-17
Glutamate Transporter Activators and Methods Using Same App 20200255445 - Kind Code	2020-08-13
Treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder Grant 10,695,302 - Kortagere	2020-06-30
D.sub.3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease Grant 10,543,180 - Kortagere , et al. Ja	2020-01-28
Compounds And Methods Of Treating Or Ameliorating An Il-1r-mediated Disease Or Disorder Using Same App 20190367503 - KORTAGERE; Sandhya ; et al.	2019-12-05
Pxr Agonists And Uses Thereof For Gut Barrier Dysfunction Treatment And Prevention App 20190367475 - Mani; Sridhar ; et al.	2019-12-05
Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same Grant 10,428,059 - Kortagere , et al. October 1, 2	2019-10-01
Novel Compositions Useful In Treating Brain-related Diseases Or Disorders And Methods Using Same App 20190241578 - KORTAGERE; Sandhya ; et al.	2019-08-08
Compositions useful in treating brain-related diseases or disorders and methods using same Grant 10,287,290 - Kortagere , et al.	2019-05-14
Novel Treatments For Attention And Cognitive Disorders, And For Dementia Associated With A Neurodegenerative Disorder App 20180092865 - KORTAGERE; Sandhya	2018-04-05
Novel Compounds And Methods Of Treating Or Ameliorating An Il-1r-mediated Disease Or Disorder Using Same App 20180030046 - KORTAGERE; Sandhya ; et al.	2018-02-01
Treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder Grant 9,861,594 - Kortagere January 9, 2	2018-01-09
Novel D3 Dopamine Receptor Agonists To Treat Dyskinesia In Parkinson's Disease App 20170246128 - KORTAGERE; Sandhya ; et al.	2017-08-31
Novel Compounds And Methods Of Treating Or Ameliorating An Il-1r-mediated Disease Or Disorder Using Same App 20170204089 - KORTAGERE; Sandhya ; et al.	2017-07-20
Novel Compositions Useful In Treating Brain-related Diseases Or Disorders And Methods Using Same App 20170190709 - KORTAGERE; Sandhya ; et al.	2017-07-06
D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease Grant 9,675,565 - Kortagere , et al. June 13, 2	2017-06-13
Compositions useful in treating brain-related diseases or disorders and methods using same Grant 9,616,065 - Kortagere , et al. April 11, 2	2017-04-11
Anti-malarial agents Grant 9,464,057 - Burrows , et al. October 11, 2	2016-10-11
Novel Treatments For Attention And Cognitive Disorders, And For Dementia Associated With A Neurodegenerative Disorder App 20160256417 - KORTAGERE; Sandhya	2016-09-08
New Anti-malarial Agents App 20160194286 - BURROWS; JEREMY ; et al.	2016-07-07
D.sub.3 dopamine receptor agonists to treat dyskinesia in parkinson's disease Grant 9,289,400 - Kortagere , et al. March 22, 2	2016-03-22
Novel Compositions Useful In Treating Brain-related Diseases Or Disorders And Methods Using Same App 20160074408 - KORTAGERE; Sandhya ; et al.	2016-03-17
Novel D3 Dopamine Receptor Agonists to Treat Dyskinesia in Parkinson's Disease App 20140228355 - Kortagere; Sandhya ; et al.	2014-08-14
Novel D3 Dopamine Receptor Agonists to Treat Dyskinesia in Parkinson's Disease App 20140228380 - Kortagere; Sandhya ; et al.	2014-08-14
Mechanism-based small-molecule parasite inhibitors Grant 8,486,987 - Welsh , et al. July 16, 2	2013-07-16
Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof App 20130165489 - Cocklin; Simon ; et al.	2013-06-27
Mechanism-based Small-molecule Parasite Inhibitors App 20110172268 - Welsh; William J. ; et al.	2011-07-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.